News
-
-
-
PRESS RELEASE
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Champions Oncology announces the full commercial launch of its radiopharmaceutical services platform, offering integrated radiopharmaceutical studies with clinically relevant isotopes and PDX tumor models -
-
-
PRESS RELEASE
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Champions Oncology granted license for radioactive materials in preclinical studies, enhancing capabilities in radiotherapeutics development. CEO Ronnie Morris highlights the importance of this milestone -
-
-
PRESS RELEASE
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
Champions Oncology announces advancements in bioanalytical services portfolio with Cytek Aurora flow cytometers integration and appointment of Troy Tremaine, MBA, for Commercial Strategy -